Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

SCNX Stock Climbs on Arbli Launch Pills and a daily pill organizer: Arbli’s liquid formulation helps patients (especially children/elderly) who can’t swallow tablets. Scienture’s stock jumped sharply on Oct. 16 after the company formally launched Arbli™ in the U.S. market. In a GlobeNewswire press release that morning, Scienture announced that Arbli™ is now shipping through major pharmaceutical wholesalers nationwide Globenewswire.…
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

Strategic Samsung Partnership GRAIL’s shares surged after it announced a deal on Oct. 16 to partner with Samsung in Asia. The binding Letter of Intent involves Samsung C&T and Samsung Electronics investing $110 million in GRAIL at $70.05 per share, with Samsung C&T to distribute the Galleri multi-cancer screening test in South Korea Investing Prnewswire. This collaboration gives Samsung “a strong…
J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

Stock Rally After Earnings Beat J.B. Hunt’s stock rallied hard on Oct. 16. Reuters reported that JBHT shares “rose nearly 16% in early trading on Thursday” (Oct 16) after the company’s cost-cutting drove a stronger-than-expected profit Reuters. Traders noted a similar jump (about 18%) according to market news on StockTwits Stocktwits. The surge pushed JBHT to multi-week highs (roughly mid-$160s…
Whitehawk Therapeutics Stock Rockets on AI Partnership – What Investors Need to Know

Whitehawk Therapeutics Stock Rockets on AI Partnership – What Investors Need to Know

Whitehawk’s stock popped dramatically on Oct. 16 after news of the Tempus collaboration. Shares had been around $2 per share in mid-October Stockinvest, but the new AI partnership sent them soaring in early trading. By mid-day Oct. 16, various data sites showed WHWK up roughly 50–67% on the session Investing. (For comparison, it had already gained ~6.6% on Oct. 15…
Polestar Stock Skyrockets on Strong EV Sales and New Tech – What’s Next?

Polestar Stock Skyrockets on Strong EV Sales and New Tech – What’s Next?

Recent Stock Performance Polestar’s stock has been volatile in October 2025. After Q3 sales news on Oct. 9, PSNY climbed modestly (Reuters noted a ~+2% premarket rise Reuters), ending around $0.91 on Oct 15. By Oct 16 it was about $0.94 Investing. In contrast, the PSNYW warrants (which had languished at ~$0.20) saw a huge rally to ~$0.35 on Oct…
Charles Schwab Stock Surges on Blowout Q3 Results, Analysts Eye More Upside

Charles Schwab Stock Surges on Blowout Q3 Results, Analysts Eye More Upside

Schwab’s Q3 results illustrate a strong growth cycle: client assets are growing at a record pace and fee & trading revenues are robust. As Wurster put it, this reflects “strengthening organic growth trends” and “favorable macroeconomic tailwinds” powering another “quarter of record revenue and earnings per share” Aboutschwab. With analysts updating ratings upward (as detailed by Benzinga and Capital.com) and…
Auddia (AUUD) Stock Skyrockets on AI/Web3 Pivot – Microcap Audio Tech’s Big Day

Auddia (AUUD) Stock Skyrockets on AI/Web3 Pivot – Microcap Audio Tech’s Big Day

In summary, Auddia’s stock is catching fire as the company pivots into AI and Web3. The Oct. 16 surge reflects optimism about the business-combination plan and new B2B model. As one commentator notes, the move “coincides with Auddia’s strategic transformation” to emphasize AI in audio 247Marketnews Gurufocus. CEO Thramann himself emphasized the vision: “I believe there is an incredible opportunity…
Praxis Precision (PRAX) Stock Skyrockets on Game-Changing Phase 3 Results – What Experts Say

Praxis Precision (PRAX) Stock Skyrockets on Game-Changing Phase 3 Results – What Experts Say

Market Outlook With the stock now trading well above $150, investors are debating how much further PRAX could rise. If ulixacaltamide wins approval, analysts believe it could capture a sizable ET market. However, success in neurology trials can be binary – failures or setbacks could send the stock sharply down. Looking ahead, Praxis expects more data by late 2025/early 2026…
Travelers Companies (TRV) Q3 Earnings Blow Past Estimates as Catastrophe Losses Tumble – Analysts Weigh In

Travelers Companies (TRV) Q3 Earnings Blow Past Estimates as Catastrophe Losses Tumble – Analysts Weigh In

Stellar Q3 Lifts Earnings – Stock Reaction Travelers’ Q3 earnings report (released Oct. 16 before markets) showed robust profitability and low catastrophe losses. Core income jumped to $8.14 per diluted share Reuters, crushing prior-year ($5.24) and analyst forecasts Benzinga. Net income was ~$1.888B (≈$8.24/sh), up ~52% from 2024, on revenues of $12.47B (above forecasts) Tokenist. Underwriting gains more than doubled…
Nestlé Shares Soar 8% on Surprise Q3 Sales, 16,000-Job Cut Plan – What’s Next?

Nestlé Shocks Investors: 8% Stock Rally After Blowout Q3 and 16,000 Jobs on the Line

Key Facts: Nestlé’s stock jumped about 8% on Oct. 16 – its steepest one-day gain since 2008 Swissinfo ts2.tech. That followed a surprise 4.3% rise in Q3 organic sales (versus ~3.7% expected) Reuters, with its volume metric (real internal growth) at +1.5% (far above the +0.3% forecast) Reuters. New CEO Philipp Navratil announced a costly “turnaround” plan: 16,000 job cuts…
Critical Metals (CRML) Stock Explodes on Rare-Earth Boom – Gains Skyrocket Amid U.S. Investment Buzz

Critical Metals (CRML) Stock Explodes on Rare-Earth Boom – Gains Skyrocket Amid U.S. Investment Buzz

Stock Price and Recent Performance As of Oct.16, 2025 midday, CRML trades in the mid-$20s, rebounding from Oct.15’s close at $22.72 Marketbeat. That day’s 24% plunge followed a parabolic run higher: in early Oct the stock was only single digits, yet by Oct.13 it hit a 52-week high ($21.45 intraday) and by Oct.14 briefly traded near $32 ts2.tech. These gains…
1 373 374 375 376 377 584

Stock Market Today

  • Philip Morris International Shares Show 16% Undervaluation Despite Recent Rally
    January 24, 2026, 1:15 PM EST. Philip Morris International's stock surged 40.7% over the past year, closing recently at $173.02. Despite this strong share price growth, a Discounted Cash Flow (DCF) analysis suggests the shares remain undervalued by 16.2%, with an estimated fair value of $206.50. The company is shifting focus towards smoke-free and reduced-risk products amid evolving tobacco industry regulations. Its Price-to-Earnings (P/E) ratio is also under review as investors gauge earnings relative to price. However, valuation scores show Philip Morris scores only 1 out of 6 for undervaluation, indicating some caution. The stock's appeal lies in its future cash flow potential, despite recent momentum already priced in.
Go toTop